SYNVISC-ONE RECALL OF POPULAR ARTHRITIS INJECTION
In December 2017, pharmaceutical manufacturer Sanofi Genzyme announced a voluntary recall for a single lot of its Synvisc-One arthritis syringes. An internal investigation discovered the appearance of unanticipated microbial contamination.
WHAT IT MEANS FOR PATIENTS
A contaminated syringe could cause infections in patients suffering from osteoarthritis. Microbial contamination occurs when medication is externally “invaded” by infectious material such as bacteria, yeast, mold, fungi, and even certain viruses. As of early February 2018, Sanofi Genzyme still has not publicly disclosed which microbial material caused the Synvisc-One recall.
If you’ve suffered harm from a Synvisc-One syringe, you deserve to be compensated for your damages. Contact Terry Bryant Accident & Injury Law for a free consultation by filling out our online contact form or calling us toll-free at (800) 444-5000.
CASES WE ARE HANDLING
We are focusing our investigation of claims with the following factors:
- You received your injection between October 25, 2017 and December 25, 2017;
- You had an adverse reaction within 7 days of the injection; and
- You required IV antibiotics or some other procedure to remove infection.
If this sounds familiar and applies to your or your loved one’s situation, contact Terry Bryant Accident & Injury Law to speak to our legal team immediately.
A BACKGROUND ON THIS RECALL
The recalled lot (number (7RSL021) comprising 18,000 Synvisc-One syringes, was distributed in virtually all 50 states during the last week in October and the first week of November 2017.
Syringes from the aforementioned lot produced a “surge” of adverse event reports. However, no deaths have been linked to the Synvisc-One arthritis syringe recall.
The Synvisc-One gel is made from a substance called hyaluronan, which is an organic derivative of chicken combs. Hyaluronan is also a chemical in the human body’s synovial fluid, which acts like a lubricant and a shock absorber, allowing the knee – and other joints – to function normally. The Synvisc-One gel is injected directly into the knee by a doctor. One injection can deliver up to six months of knee pain relief.
WHAT ARE THE SYMPTOMS?
Patients suffering from contaminated syringes reported suffering one or more of the following symptoms:
- Knee pain ranging from acute to general discomfort
- Swelling in the knee
- Difficulty walking
- Limited range of motion in the knee
- A “warm” sensation in and around the knee
- Redness around the knee
- Minor swelling due to fluid build-up in or around the knee.
WHY THESE PRODUCTS HAVE BEEN USED SO FREQUENTLY
Synvisc-One has been a consistent financial success for its manufacturer, Sanofi Genzyme, which reported almost $410 million in gross sales during 2016. Synvisc-One was approved by the Food and Drug Administration (FDA) in 2009 to alleviate pain from knee osteoarthritis. And though doctors began using this medication exclusively to relieve pain in arthritic knees, over time it has been used to ease symptoms of arthritis in other joints as well. Sanofi Genzyme’s recall only addresses issues with knee pain.
So if you believe it was administered in another joint (elbows, wrist, ankle, etc.) check with your doctor. This is the first recall of Synvisc-One, and no previous negative events of any kind have been reported.
It’s currently not known how these syringes became contaminated. Doctors and pharmacies with unused Synvisc-One syringes from the recalled lot – manufactured at the company’s plant in Ridgefield, New Jersey – have returned them.
INJURED BY A DEFECTIVE SYNVISC-ONE SYRINGE? HERE’S WHAT TO DO.
If you or a loved one was injured by any defective or recalled drug, Terry Bryant Accident & Injury Law can assist you in filing a defective product claim against the drug manufacturer. We work on our patients’ behalf to hold negligent drug manufacturers liable for the harm they cause to patients who used their dangerous medications.
We will first evaluate your situation, then guide you through the legal process, serve as your advocate, assertively negotiate a settlement which is acceptable to you and, if necessary, press your case for compensation in court.
HOW LEGAL ACTION CAN HELP
The sort of compensation you can receive from an injury claim against a defective drug manufacturer can include:
- All medical costs for past, present, and future treatment
- The costs from temporary or permanent future disability
- Past, present, and future lost income if you cannot work
- Pain and suffering – including emotional distress
- Punitive damages, if appropriate.
Any defective prescription drug case can be complex, costly, and time-consuming. The manufacturer’s legal team aggressively defends its client. Same goes for their insurance company. So, it is not uncommon for some time to pass before a favorable resolution is reached. Sometimes there’s a trial. But most of the time a settlement is negotiated, and a trial is avoided.
When you hire defective product lawyers like Terry Bryant Accident & Injury Law, you have experienced trial lawyers and a seasoned support staff to help you navigate the litigation process and effectively manage your case through every step of the process. This leaves you free to focus solely on your medical treatment and full recovery, relieved from the daily burden of dealing with the legal process, insurance claims, paperwork, and case management.
If you or someone in your family is being treated for a defective Synvisc-One injection from the drug manufacturer Sanofi Genzyme’s contaminated lot number 7RSL021, contact the defective drug recall lawyers at the Terry Bryant Law Firm for a free consultation by filling out our simple online contact form or calling (800) 444-5000.